RPL3P9

Across TCGA pan-cancer cohorts, RPL3P9 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RPL3P9’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL3P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL3P9 is over-expressed in tumor, although a few such as BLCA and HNSC show the opposite, repressed pattern.

COAD, BLCA, and KIRC are the cancer types where RPL3P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL3P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+1.007	<.001	9	view →
BLCA	Male	IV	−0.367	<.001	5	view →
KIRC	Female	III,IV	+0.169	.003	5	view →
HNSC	Female	IV	−0.215	.008	4	view →
BRCA	Female	All	−0.111	<.001	4	view →
THCA	All	II,III,IV	+0.169	.021	2	view →
STAD	Male	IV	+0.180	.029	1	view →
LIHC	Female	II,III,IV	+0.146	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RPL3P9–COAD

Open the COAD breakdown →